Building Programs and People
November 28, 2025
-
9 min
7 Key Takeaways
-
1
Pathology combines biological sciences and clinical research.
-
2
The field has undergone significant revolutions: immunohistochemistry, molecular diagnostics, and AI integration.
-
3
The UPenn department excels in NIH funding and research advancements.
-
4
AI and machine learning will shape pathology's future practices.
-
5
Antibody-drug conjugates offer new therapeutic pathways.
-
6
Leadership in pathology focuses on developing talent and integrity.
-
7
Engaging with global scientific communities enhances research visibility.
Pathology has evolved significantly over the years, driven by scientific advancements and a commitment to better clinical care. The interviewee, a department head at the University of Pennsylvania, reflects on his journey from early interest in pathology to leadership roles, emphasizing the importance of integrating molecular diagnostics and AI into the field. He sees potential in antibody-drug conjugates and envisions a future where pathologists can leverage technology to enhance cancer treatment. His leadership philosophy centers on cultivating talent and focusing on the impact of educational efforts in pathology.
Listen Tab content
